Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07180953

Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty

Route of Dexamethasone Administration in iPACK and ACB for Total Knee Replacement: A Randomized Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
All
Age
65 Years – 100 Years
Healthy volunteers
Not accepted

Summary

"The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in iPACK With ACB for Total Knee Arthroplasty" - written in plain language according to ClinicalTrials.gov standards: The goal of this clinical trial is to learn how the route of dexamethasone administration (either through the vein or nerve block) affects pain and inflammation in people having total knee replacement surgery. All participants will receive two types of nerve blocks before surgery: an iPACK block and an adductor canal block (ACB), which help control pain after the operation. The main questions the study aims to answer are: Does injecting dexamethasone into the nerve block reduce pain more effectively than giving it by vein? Which method leads to a lower inflammatory response after surgery? Researchers will compare the two groups to see which route offers better pain relief and less swelling after knee surgery. Participants will: Be randomly assigned to receive dexamethasone either in the nerve block or by IV Receive standard care for total knee replacement Rate their pain and have blood tests after surgery to measure inflammation

Conditions

Interventions

TypeNameDescription
DRUGNaCl 0.9%iPACK block with Adductor Canal Block (2 x 20ml 0.2% ropivacaine + 1ml 0.9% NaCl) + 2ml 0.9% NaCl iv
DRUGDexamethasone 4mgiPACK block with Adductor Canal Block (2 x 20ml 0.2% ropivacaine + 1ml 0.9% NaCl) + 4mg Dexamethasone iv
DRUGDexamethasone 4mgiPACK block with Adductor Canal Block (2 x 20ml 0.2% ropivacaine + 2mg Dexamethasone) + 2ml 0.9% NaCl iv

Timeline

Start date
2025-09-01
Primary completion
2026-09-30
Completion
2026-10-30
First posted
2025-09-18
Last updated
2026-02-02

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT07180953. Inclusion in this directory is not an endorsement.